查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2094745

病毒學檢體採集市場​​－全球市場預測（2026-2032年）

Virology Specimen Collection Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，病毒學檢體體採集市場​​將成長至 84.2 億美元，複合年成長率為 10.55%。

主要市場統計數據
基準年 2025 41.7億美元
預計年份：2026年 46億美元
預測年份 2032 84.2億美元
複合年成長率 (%) 10.55%

病毒檢體採集是感染疾病診斷的核心環節，它不僅關乎病患檢體採集的質量，更與核酸增幅檢查、抗原檢測、病毒培養、定序和血清學檢測的可靠性密切相關。此類標本包括鼻咽拭子、口咽拭子、鼻拭子、唾液、血液、糞便、尿液、腦脊髓液、病灶部位、生殖器、結膜和環境檢體，以及拭子、病毒運輸培養基、無菌容器、採集管、生物安全包裝、低溫運輸系統和數位化儲存歷史管理流程。呼吸道病毒監測、性行為感染感染檢測、血源性病毒篩檢、蟲媒病毒感染疾病監測、集體爆發防治、移植和免疫力缺乏功能低下患者的護理、性行為感染感染評估以及基於污水的流行病學調查等，都對病毒標本採集的需求產生了影響。

品質在這一領域至關重要，因為採集、標記、運輸、儲存或預分析過程中的任何錯誤都可能降低檢測靈敏度、增加無效結果、延遲公共衛生應對措施並影響臨床決策。公共衛生機構、檢查室標準化機構和生物安全機構發布的循證採集方案強調選擇合適的檢體類型、確定症狀出現後的時間、使用合適的拭子材質、保證足夠的樣本量、控制溫度、使用防漏包裝、貼上生物危害標籤以及記錄運輸條件。隨著診斷平台變得更加靈敏和分散化，病毒學檢體採集正從一項常規臨床任務演變為醫療保健系統、公共衛生檢查室、研究網路和診斷服務供應商的一項策略能力。

病毒學檢體採集領域的變革性變化

病毒學檢體採集的格局正因近期全球感染疾病的經驗教訓、分子診斷技術的擴展以及對快速、標準化和擴充性檢體採集流程日益成長的需求而發生重塑。呼吸道病毒檢測正從季節性流感轉向多重檢測，能夠從單一檢體中檢測出流感病毒、SARS-CoV-2、呼吸道融合細胞病毒、腺病毒、副流感病毒和其他病原體。這項轉變凸顯了檢驗的採集設備和運輸條件的重要性，這些條件能夠確保病毒RNA和DNA在各種檢測平台上的完整性。

人工智慧對檢體收集的累積影響

人工智慧正逐步對病毒學檢體收集領域產生累積影響，它能夠改善檢體的採集、運輸和優先排序的地點、時間和方式。人工智慧驅動的需求預測可以利用症候群監測、急診科趨勢、檢查室陽性模式、氣候徵兆、病媒活動和移動數據，在檢測需求高峰到來之前最佳化拭子、運輸培養基、低溫運輸資源和人員的分配。這在呼吸道病毒爆發、蟲媒病毒爆發以及新型病原體快速傳播期間尤其重要。

關於病毒學檢體體採集的關鍵區域性見解

在亞太地區，病毒學檢體採集受到許多因素的影響，包括都市區密度高、呼吸道病毒檢測需求旺盛、登革熱和其他蟲媒病毒感染疾病再次出現、通用感染疾病溢出的風險，以及鑑於近期疫情經驗而對檢測網路進行的大規模投資。該地區各國正在加強分子診斷能力、機場和邊境的健康監測以及基因測序流程，並將檢體完整性、元資料收集和低溫運輸可靠性置於公共衛生工作的核心。

針對病毒學檢體採集的關鍵群體特定見解

北約成員國正在努力解決從民用和軍用醫療系統中採集病毒學檢體的問題。在作戰環境、人道援助行動和跨境衛生安全項目中，可部署的診斷技術、安全運輸、現場檢體採集規程以及新興感染疾病監測至關重要，因為在這些環境中，必須在傳統檢查室環境之外維護檢體的完整性和生物安全性。

主要國家對病毒檢體體採集的了解程度

中國正在拓展分子診斷、呼吸道病原體監測、基因測序和感染疾病監測能力，因此標準化的檢體採集、高通量檢體處理和完整的流行病學元元資料至關重要。美國擁有覆蓋醫院、公共衛生實驗室、門診診所、藥房、家庭檢體採集項目和污水監測網路的廣泛病毒學檢體採集能力，重點在於標準化的分子檢測流程、電子報告和基因組監測。在日本，先進的臨床實驗室系統、老齡化社會以及對呼吸道病毒監測的高度重視，為高品質的檢體處理、快速診斷和嚴格的分析前品管提供了支持。印度面臨廣泛的病毒學檢體採集需求，涵蓋呼吸道感染疾病、登革熱、屈公病、病毒性肝炎、愛滋病、腦炎和集體爆發應對，尤其注重將服務範圍擴大到大都會圈檢查室以外的地區。

為行業領導者提供的實用建議

產業領導者應將分析前品質作為一項策略差異化優勢，具體措施包括：在醫療機構中標準化檢體採集流程；檢驗採集設備對目標檢測的適用性；以及加強對檢體類型、採集時間、拭子採集技術、生物安全、包裝和運輸條件等方面的培訓。投資於數位化儲存歷史管理系統、條碼標籤、電子申請單以及與實驗室資訊系統 (LIS) 的整合，可以減少錯誤並縮短檢測結果報告時間。

病毒檢體體採集與分析的調查方法

病毒學檢體採集的嚴謹調查方法需要結合一級調查和二級調查，以評估臨床、操作、監管和公共衛生趨勢。二級調查應仔細審查國家公共衛生機構、世界衛生組織、檢查室認證機構、生物安全標準、同行評審研究、監測報告、臨床實驗室指南以及與檢體類型、運輸培養基、穩定性、儲存溫度、包裝和診斷相容性相關的監管指南。

結論

病毒檢體採集是準確診斷、集體爆發檢測、基因組監測和提升醫療系統韌性的基礎能力。該領域正朝著更加標準化、數位化、以患者為中心且注重生物安全的檢體採集模式發展，以支持常規臨床檢測和緊急應變。在呼吸道病毒監測、蟲媒病毒監測、血源性病毒應對計畫、性行為感染感染診斷、性行為感染檢體、移植後監測和污水流行病學等領域，可靠的檢體和完整元資料需求日益成長。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：病毒學檢體採集市場​​：依產品類型分類

  • 病毒轉運培養基（VTM）
  • 通用傳輸媒體（UTM）
  • 分子轉運介質（MTM）
  • 採血套裝
  • 採血管

第8章：病毒學檢體採集市場：依技術分類

  • 免疫檢測
  • 聚合酵素鏈鎖反應
  • 快速檢測
    • 比色檢測
    • 側向流
  • 定序
    • 次世代定序
    • 桑格定序

第9章：病毒學檢體採集市場​​：依疾病類型分類

  • 肝炎
    • 甲型肝炎
    • B型肝炎
    • C型肝炎
  • HIV
  • 流感
    • 甲型流感
    • 乙型流感
  • SARS-CoV-2

第10章：病毒學檢體採集市場：依樣本類型分類

  • 血液檢體
  • 糞便檢體
  • 唾液檢體
  • 尿液檢體

第11章 病毒學檢體採集市場​​：依最終使用者分類

  • 診斷檢查室
    • 臨床實驗室
    • 參考實驗室
  • 醫院
  • 照護現場
    • 診所
    • 現場檢查設施
  • 研究機構
    • 學術機構
    • 政府機構

第12章 病毒學檢體採集市場​​：依通路分類

  • 直銷
  • 銷售代理
    • 當地經銷商
    • 全國銷售代理
  • 線上管道
    • 企業網站
    • 第三方電子商務

第13章：病毒學檢體採集市場​​：依地區分類

  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 非洲
  • 中東

第14章：病毒學檢體採集市場​​：依組別分類

  • NATO
  • G7
  • BRICS
  • EU
  • ASEAN
  • GCC

第15章 病毒學檢體採集市場​​：依國家分類

  • 中國
  • 美國
  • 日本
  • 印度
  • 德國
  • 英國
  • 澳洲
  • 法國
  • 韓國
  • 義大利
  • 加拿大
  • 俄羅斯
  • 巴西
  • 墨西哥
  • 西班牙

第16章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • BioFire Diagnostics LLC
  • Bionote Inc.
  • Copan Italia SpA
  • DiaSorin SpA
  • F. Hoffmann-La Roche Ltd.
  • GenMark Diagnostics Inc.
  • Gentueri Inc.
  • Hardy Diagnostics
  • Hologic Inc.
  • Huachenyang（Shenzhen）Technology Co., Ltd.
  • Jiangsu HXRT MD Co., Ltd.
  • Jinan Babio Biotechnology Co., Ltd.
  • Luminex Corporation
  • Medico Technology Co., Ltd.
  • Meridian Bioscience Inc.
  • Miraclean Technology Co., Ltd.
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • Savyon Diagnostics Ltd.
  • Seegene Inc.
  • Shenzhen Cleanmo Technology Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • Titan Biotech Limited
Product Code: MRR-8201ABF20F0B

The Virology Specimen Collection Market is projected to grow by USD 8.42 billion at a CAGR of 10.55% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.17 billion
Estimated Year [2026] USD 4.60 billion
Forecast Year [2032] USD 8.42 billion
CAGR (%) 10.55%

Virology specimen collection is the front end of infectious disease diagnostics, linking patient sampling quality with the reliability of nucleic acid amplification tests, antigen assays, viral culture, sequencing, and serology. The category includes nasopharyngeal, oropharyngeal, nasal, saliva, blood, stool, urine, cerebrospinal fluid, lesion, genital, conjunctival, and environmental specimens, alongside swabs, viral transport media, sterile containers, collection tubes, biosafety packaging, cold-chain systems, and digital chain-of-custody workflows. Demand is shaped by respiratory virus surveillance, sexually transmitted infection testing, blood-borne virus screening, arboviral disease monitoring, outbreak preparedness, transplant and immunocompromised patient care, congenital infection evaluation, and wastewater-based epidemiology.

Quality is central to this field because errors at collection, labeling, transport, storage, or pre-analytical handling can compromise test sensitivity, increase invalid results, delay public health response, and undermine clinical decision-making. Evidence-based collection protocols issued by public health agencies, laboratory standards bodies, and biosafety authorities emphasize correct specimen type selection, timing relative to symptom onset, appropriate swab materials, adequate volume, temperature control, leak-proof packaging, biohazard labeling, and documented transport conditions. As diagnostic platforms become more sensitive and decentralized, virology specimen collection is evolving from a routine clinical task into a strategic capability for healthcare systems, public health laboratories, research networks, and diagnostic service providers.

Transformative Shifts in the Virology Specimen Collection Landscape

The virology specimen collection landscape is being reshaped by lessons from recent global outbreaks, the expansion of molecular diagnostics, and the growing need for rapid, standardized, and scalable sampling pathways. Respiratory virus testing has moved beyond seasonal influenza toward multiplex panels that can detect influenza viruses, SARS-CoV-2, respiratory syncytial virus, adenoviruses, parainfluenza viruses, and other pathogens from a single specimen. This shift increases the importance of validated collection devices and transport conditions that preserve viral RNA or DNA across diverse testing platforms.

Self-collection and minimally invasive sampling are also transforming access. Nasal swabs, saliva collection, dried blood spot sampling, and home-based collection kits can reduce facility burden and improve testing reach when supported by clear instructions, identity verification, specimen stability data, and reliable logistics. At the same time, biosafety expectations have strengthened, with greater use of triple packaging, exposure-minimizing workflows, personal protective equipment guidance, and temperature-monitored transport. Another major shift is the integration of virology specimen collection with genomic surveillance. Specimens collected for routine diagnostics can support variant tracking and outbreak investigation when consent, metadata completeness, specimen integrity, and laboratory interoperability are properly managed.

The industry is also moving toward digitalized pre-analytical systems. Barcode labeling, electronic requisitions, sample tracking, mobile phlebotomy coordination, and laboratory information system connectivity help reduce misidentification, improve turnaround time, and support auditability. Together, these changes are elevating specimen collection from an operational function to a critical pillar of diagnostic quality, public health intelligence, and pandemic readiness.

Cumulative Impact of Artificial Intelligence on Specimen Collection

Artificial intelligence is beginning to create cumulative impact across virology specimen collection by improving where, when, and how specimens are collected, transported, and prioritized. AI-enabled demand planning can use syndromic surveillance, emergency department trends, laboratory positivity patterns, climate signals, vector activity, and mobility data to guide allocation of swabs, transport media, cold-chain resources, and staffing before testing pressure peaks. This is especially relevant for respiratory virus seasons, arboviral outbreaks, and rapidly spreading novel pathogens.

In collection workflows, AI-supported tools can reduce pre-analytical error by verifying requisition completeness, flagging mismatched patient identifiers, prompting correct specimen type based on test orders, and identifying missing metadata needed for surveillance. Computer vision, digital checklists, and decision support can strengthen training and competency assessment for swab technique, packaging compliance, and biosafety procedures. In logistics, route optimization can shorten transit time, prioritize temperature-sensitive specimens, and reduce the risk of degradation before molecular testing or viral isolation.

AI also strengthens downstream value by improving specimen triage for sequencing, outbreak investigation, and antiviral stewardship programs. Algorithms can help select specimens with adequate viral load, representative geography, unusual clinical patterns, or epidemiological significance. However, implementation requires governance around data privacy, bias, cybersecurity, clinical validation, and human oversight. The most defensible AI use cases are those that enhance standardized collection protocols, improve traceability, and support faster public health response without replacing laboratory quality management systems.

Key Regional Insights Across Virology Specimen Collection

In Asia-Pacific, virology specimen collection is shaped by dense urban populations, high respiratory virus testing needs, recurring dengue and other arboviral disease activity, zoonotic spillover risks, and major investments in laboratory networks following recent pandemic experience. Countries across the region have strengthened molecular diagnostic capacity, airport and border health surveillance, and genomic sequencing pipelines, making specimen integrity, metadata capture, and cold-chain reliability central to public health operations.

Europe benefits from harmonized public health coordination, well-established clinical laboratory systems, and cross-border disease monitoring frameworks. Respiratory virus surveillance, blood safety screening, sexually transmitted infection diagnostics, viral hepatitis programs, and genomic monitoring continue to drive requirements for standardized specimen collection, secure transport, and interoperable laboratory data across national health systems.

North America has a mature virology testing ecosystem supported by hospital laboratories, public health laboratories, reference testing networks, retail and community sampling models, home collection pathways, and wastewater surveillance programs. The region places strong emphasis on laboratory accreditation, biosafety standards, electronic ordering, chain-of-custody, and integration between diagnostic reporting and disease surveillance systems.

Latin America's virology specimen collection priorities are closely tied to arboviruses such as dengue, Zika, and chikungunya, alongside respiratory viruses, hepatitis, HIV, and emerging zoonotic threats. Geographic diversity and unequal access to cold-chain logistics make sample stabilization, regional laboratory connectivity, and community-based collection strategies essential for timely diagnosis and surveillance.

Across Africa, collection systems must address high burdens of HIV, viral hepatitis, hemorrhagic fever threats, respiratory infections, measles, polio surveillance, and arboviral disease risks while overcoming infrastructure constraints in remote settings. Dried blood spots, mobile collection teams, sample referral networks, and temperature-stable transport approaches are particularly important for expanding virology testing access and strengthening outbreak detection.

In the Middle East, virology specimen collection is influenced by high travel connectivity, mass gathering health preparedness, migrant workforce health programs, and respiratory pathogen monitoring. Investments in hospital infrastructure, molecular testing, and biosafety capabilities support demand for reliable swabs, viral transport media, rapid sample routing, and digital traceability across centralized and decentralized care settings.

Key Group Insights for Virology Specimen Collection

NATO member countries approach virology specimen collection through both civilian health systems and military medical readiness. Deployable diagnostics, secure transport, field collection protocols, and surveillance for emerging infectious diseases are important in operational settings, humanitarian missions, and cross-border health security planning, where specimen integrity and biosafety must be maintained outside conventional laboratory environments.

The G7 group has highly developed diagnostic and public health laboratory capacity, with growing emphasis on pandemic preparedness, integrated respiratory virus surveillance, genomic monitoring, antiviral stewardship support, and secure supply chains for collection devices. Digital specimen tracking, quality assurance, biosafety compliance, and interoperable reporting are central features of these systems.

BRICS countries present diverse virology specimen collection needs due to large populations, varied health system structures, tropical and temperate disease profiles, and differing levels of laboratory decentralization. Priorities include scaling molecular testing, improving specimen referral systems, supporting sequencing readiness, strengthening sample logistics, and ensuring equitable access to reliable collection supplies.

The European Union supports standardized virology specimen collection through regional surveillance coordination, laboratory quality frameworks, data interoperability initiatives, and cross-border health security mechanisms. Consistent collection protocols and comparable metadata are especially important for respiratory virus monitoring, genomic surveillance, vaccine effectiveness studies, blood safety, and outbreak investigation.

ASEAN countries are prioritizing virology specimen collection in the context of respiratory virus surveillance, dengue control, zoonotic spillover monitoring, and cross-border outbreak preparedness. The group's mix of island geographies, megacities, and rural communities increases the need for decentralized sampling models, robust transport media, and laboratory referral networks capable of moving specimens rapidly and safely.

The GCC is strengthening specimen collection systems through investments in advanced healthcare infrastructure, travel medicine, mass gathering preparedness, and digital health platforms. Virology workflows in the group often emphasize rapid molecular testing, biosafety, electronic sample tracking, coordinated surveillance for respiratory pathogens, and detection of imported infections.

Key Country Insights in Virology Specimen Collection

China has expanded molecular diagnostics, respiratory pathogen surveillance, genomic sequencing, and infectious disease monitoring capacity, making collection standardization, high-throughput sample handling, and complete epidemiological metadata essential. The United States has extensive virology specimen collection capacity spanning hospitals, public health laboratories, outpatient clinics, pharmacies, home collection programs, and wastewater monitoring networks, with strong emphasis on standardized molecular testing workflows, electronic reporting, and genomic surveillance. Japan's advanced clinical laboratory systems, aging population, and respiratory virus surveillance priorities support high-quality specimen handling, rapid diagnostics, and careful pre-analytical quality control. India faces broad virology specimen collection requirements across respiratory infections, dengue, chikungunya, viral hepatitis, HIV, encephalitis, and outbreak response, with major emphasis on expanding access beyond metropolitan laboratories.

Germany's laboratory infrastructure, clinical virology expertise, and strong quality management orientation reinforce demand for validated collection devices, standardized transport, and reliable reporting. The United Kingdom uses integrated public health surveillance, genomic sequencing capability, sexual health services, and hospital diagnostic networks to support advanced virology specimen collection practices. Australia combines hospital and public health laboratory strength with remote-area logistics, respiratory virus monitoring, and biosecurity surveillance. France places emphasis on hospital virology, public health surveillance, overseas territory health monitoring, and respiratory and arboviral testing preparedness. South Korea's experience with large-scale testing, digital tracing infrastructure, and infectious disease preparedness supports efficient sample collection, rapid transport, and laboratory integration.

Italy and Spain maintain strong hospital and public health laboratory systems with significant respiratory virus, blood-borne virus, and sexually transmitted infection testing needs, supported by standardized sampling and transport practices. Canada's approach is supported by provincial laboratory systems, respiratory virus monitoring, remote community access considerations, and national public health coordination, making sample transport reliability and cold-chain management important across large geographies. Russia's expansive geography and infectious disease surveillance requirements heighten the importance of sample logistics, regional laboratory coverage, and cold-chain control. Brazil's large population, dengue and other arboviral disease burden, influenza surveillance, HIV programs, and regional laboratory networks make specimen referral systems, biosafety, and molecular testing readiness critical. Mexico combines respiratory virus testing, arboviral surveillance, HIV and hepatitis diagnostics, and cross-border public health coordination, with ongoing needs for consistent specimen quality across urban and rural settings.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize pre-analytical quality as a strategic differentiator by standardizing specimen collection protocols across care settings, validating collection devices for intended assays, and reinforcing training on specimen type, timing, swab technique, biosafety, packaging, and transport conditions. Investment in digital chain-of-custody systems, barcode labeling, electronic requisitions, and laboratory information system integration can reduce errors and improve turnaround time.

Organizations should diversify collection formats to include clinician-collected, self-collected, mobile, home-based, and community-based models where clinically validated and operationally feasible. Building resilient supply chains for swabs, viral transport media, sterile tubes, preservatives, packaging, and cold-chain materials is essential for surge readiness. Leaders should also align collection workflows with genomic surveillance needs by improving metadata completeness, consent pathways, residual specimen handling, and specimen triage criteria.

AI and automation should be adopted selectively to strengthen demand planning, workflow routing, quality checks, logistics optimization, and specimen selection for sequencing. Implementation should be paired with privacy safeguards, algorithm validation, cybersecurity controls, and human review. Finally, cross-sector collaboration between clinical laboratories, public health authorities, logistics providers, digital health teams, and frontline collection sites will be essential to maintain specimen integrity during routine testing and public health emergencies.

Research Methodology for Virology Specimen Collection Analysis

A rigorous research methodology for virology specimen collection should combine primary and secondary evidence to evaluate clinical, operational, regulatory, and public health dynamics. Secondary research should review guidance from national public health agencies, international health organizations, laboratory accreditation bodies, biosafety standards, peer-reviewed studies, surveillance reports, clinical testing guidelines, and regulatory documents related to specimen type, transport media, stability, storage temperature, packaging, and diagnostic compatibility.

Primary research should include structured interviews with clinical microbiologists, virologists, laboratory directors, infection prevention specialists, public health officials, procurement leaders, logistics experts, and frontline collection professionals. Validation should triangulate findings across diagnostic use cases such as respiratory viruses, blood-borne viruses, sexually transmitted viral infections, arboviruses, enteric viruses, central nervous system infections, congenital infections, transplant-related viral monitoring, and environmental surveillance.

The methodology should assess collection devices, pre-analytical workflows, specimen stability evidence, biosafety requirements, digital traceability, training practices, and integration with molecular testing and sequencing. Regional and country-level analysis should account for healthcare infrastructure, disease burden, laboratory network maturity, cold-chain capacity, regulatory requirements, and public health surveillance priorities. Findings should be quality-checked to avoid unsupported claims, estimation language, or forecasting assumptions.

Conclusion

Virology specimen collection has become a foundational capability for accurate diagnostics, outbreak detection, genomic surveillance, and health system resilience. The sector is moving toward more standardized, digital, patient-centered, and biosafe collection models that support both routine clinical testing and emergency response. Respiratory virus monitoring, arboviral surveillance, blood-borne virus programs, sexually transmitted infection diagnostics, congenital infection assessment, transplant monitoring, and wastewater epidemiology are reinforcing the need for reliable specimens and complete metadata.

Artificial intelligence, decentralized collection, self-sampling, and improved logistics can deliver measurable operational benefits when implemented within validated quality systems. Regional differences in disease burden, infrastructure, regulation, and laboratory maturity will continue to shape collection priorities, but the core requirement remains universal: the right specimen, collected correctly, transported safely, and tested promptly. Industry leaders that strengthen pre-analytical quality, supply resilience, digital traceability, and surveillance readiness will be best positioned to support dependable virology diagnostics and faster public health action.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Virology Specimen Collection Market, by Product Type

  • 7.1. Introduction
  • 7.2. Viral Transport Media (VTM)
  • 7.3. Universal Transport Media (UTM)
  • 7.4. Molecular Transport Media (MTM)
  • 7.5. Blood Collection Kits
  • 7.6. Blood Collection Tubes

8. Virology Specimen Collection Market, by Technology

  • 8.1. Introduction
  • 8.2. Immunoassay
  • 8.3. Polymerase Chain Reaction
  • 8.4. Rapid Test
    • 8.4.1. Colorimetric Test
    • 8.4.2. Lateral Flow
  • 8.5. Sequencing
    • 8.5.1. Next-Generation Sequencing
    • 8.5.2. Sanger Sequencing

9. Virology Specimen Collection Market, by Disease Type

  • 9.1. Introduction
  • 9.2. Hepatitis
    • 9.2.1. Hepatitis A
    • 9.2.2. Hepatitis B
    • 9.2.3. Hepatitis C
  • 9.3. HIV
  • 9.4. Influenza
    • 9.4.1. Influenza A
    • 9.4.2. Influenza B
  • 9.5. SARS-CoV-2

10. Virology Specimen Collection Market, by Sample Type

  • 10.1. Introduction
  • 10.2. Blood Samples
  • 10.3. Stool Samples
  • 10.4. Saliva Samples
  • 10.5. Urine Samples

11. Virology Specimen Collection Market, by End User

  • 11.1. Introduction
  • 11.2. Diagnostic Laboratories
    • 11.2.1. Clinical Laboratories
    • 11.2.2. Reference Laboratories
  • 11.3. Hospitals
  • 11.4. Point Of Care
    • 11.4.1. Clinics
    • 11.4.2. Field Testing Sites
  • 11.5. Research Institutes
    • 11.5.1. Academic Institutes
    • 11.5.2. Government Institutes

12. Virology Specimen Collection Market, by Distribution Channel

  • 12.1. Introduction
  • 12.2. Direct Sales
  • 12.3. Distributors
    • 12.3.1. Local Distributors
    • 12.3.2. National Distributors
  • 12.4. Online Channels
    • 12.4.1. Company Website
    • 12.4.2. Third-Party E-Commerce

13. Virology Specimen Collection Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. Europe
  • 13.3. North America
  • 13.4. Latin America
  • 13.5. Africa
  • 13.6. Middle East

14. Virology Specimen Collection Market, by Group

  • 14.1. NATO
  • 14.2. G7
  • 14.3. BRICS
  • 14.4. European Union
  • 14.5. ASEAN
  • 14.6. GCC

15. Virology Specimen Collection Market, by Country

  • 15.1. China
  • 15.2. United States
  • 15.3. Japan
  • 15.4. India
  • 15.5. Germany
  • 15.6. United Kingdom
  • 15.7. Australia
  • 15.8. France
  • 15.9. South Korea
  • 15.10. Italy
  • 15.11. Canada
  • 15.12. Russia
  • 15.13. Brazil
  • 15.14. Mexico
  • 15.15. Spain

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. FPNV Positioning Matrix, 2025
  • 16.3. Market Concentration Analysis, 2025
    • 16.3.1. Concentration Ratio (CR)
    • 16.3.2. Herfindahl Hirschman Index (HHI)
  • 16.4. Recent Developments & Impact Analysis, 2025
  • 16.5. Product Portfolio Analysis, 2025
  • 16.6. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Abbott Laboratories
  • 17.2. Becton, Dickinson and Company
  • 17.3. Bio-Rad Laboratories Inc.
  • 17.4. BioFire Diagnostics LLC
  • 17.5. Bionote Inc.
  • 17.6. Copan Italia S.p.A.
  • 17.7. DiaSorin S.p.A.
  • 17.8. F. Hoffmann-La Roche Ltd.
  • 17.9. GenMark Diagnostics Inc.
  • 17.10. Gentueri Inc.
  • 17.11. Hardy Diagnostics
  • 17.12. Hologic Inc.
  • 17.13. Huachenyang (Shenzhen) Technology Co., Ltd.
  • 17.14. Jiangsu HXRT MD Co., Ltd.
  • 17.15. Jinan Babio Biotechnology Co., Ltd.
  • 17.16. Luminex Corporation
  • 17.17. Medico Technology Co., Ltd.
  • 17.18. Meridian Bioscience Inc.
  • 17.19. Miraclean Technology Co., Ltd.
  • 17.20. Quidel Corporation
  • 17.21. Randox Laboratories Ltd.
  • 17.22. Savyon Diagnostics Ltd.
  • 17.23. Seegene Inc.
  • 17.24. Shenzhen Cleanmo Technology Co., Ltd.
  • 17.25. Thermo Fisher Scientific Inc.
  • 17.26. Titan Biotech Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 25. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL VIRAL TRANSPORT MEDIA (VTM) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL VIRAL TRANSPORT MEDIA (VTM) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL VIRAL TRANSPORT MEDIA (VTM) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL UNIVERSAL TRANSPORT MEDIA (UTM) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL UNIVERSAL TRANSPORT MEDIA (UTM) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL UNIVERSAL TRANSPORT MEDIA (UTM) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MOLECULAR TRANSPORT MEDIA (MTM) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MOLECULAR TRANSPORT MEDIA (MTM) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MOLECULAR TRANSPORT MEDIA (MTM) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD COLLECTION KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD COLLECTION KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD COLLECTION KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL IMMUNOASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RAPID TEST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RAPID TEST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL RAPID TEST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL COLORIMETRIC TEST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL COLORIMETRIC TEST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL COLORIMETRIC TEST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL LATERAL FLOW MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL LATERAL FLOW MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL LATERAL FLOW MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SANGER SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SANGER SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SANGER SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HEPATITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HEPATITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HEPATITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HEPATITIS A MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HEPATITIS A MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HEPATITIS A MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HEPATITIS B MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HEPATITIS B MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HEPATITIS B MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HEPATITIS C MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HEPATITIS C MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HEPATITIS C MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HIV MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HIV MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HIV MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INFLUENZA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INFLUENZA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INFLUENZA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INFLUENZA A MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INFLUENZA A MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INFLUENZA A MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL INFLUENZA B MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INFLUENZA B MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INFLUENZA B MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SARS-COV-2 MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SARS-COV-2 MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SARS-COV-2 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BLOOD SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL STOOL SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL STOOL SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL STOOL SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SALIVA SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SALIVA SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SALIVA SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL URINE SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL URINE SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL URINE SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CLINICAL LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CLINICAL LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CLINICAL LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL POINT OF CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL POINT OF CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL POINT OF CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL FIELD TESTING SITES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL FIELD TESTING SITES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL FIELD TESTING SITES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ACADEMIC INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ACADEMIC INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ACADEMIC INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL GOVERNMENT INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL GOVERNMENT INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL GOVERNMENT INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL DISTRIBUTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL DISTRIBUTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL DISTRIBUTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL LOCAL DISTRIBUTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL LOCAL DISTRIBUTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL LOCAL DISTRIBUTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL NATIONAL DISTRIBUTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL NATIONAL DISTRIBUTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL NATIONAL DISTRIBUTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ONLINE CHANNELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ONLINE CHANNELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ONLINE CHANNELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL COMPANY WEBSITE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL COMPANY WEBSITE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL COMPANY WEBSITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL THIRD-PARTY E-COMMERCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL THIRD-PARTY E-COMMERCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL THIRD-PARTY E-COMMERCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 186. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 198. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 200. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 202. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, 2018-2032 (USD MILLION)
  • TABLE 226. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 230. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 232. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 234. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 235. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 236. NATO VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 237. NATO VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. NATO VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. NATO VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
  • TABLE 240. NATO VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 241. NATO VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. NATO VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, 2018-2032 (USD MILLION)
  • TABLE 243. NATO VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, 2018-2032 (USD MILLION)
  • TABLE 244. NATO VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. NATO VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. NATO VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 247. NATO VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 248. NATO VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 249. NATO VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 250. NATO VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 251. NATO VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 252. G7 VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 253. G7 VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. G7 VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 255. G7 VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
  • TABLE 256. G7 VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 257. G7 VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. G7 VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, 2018-2032 (USD MILLION)
  • TABLE 259. G7 VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, 2018-2032 (USD MILLION)
  • TABLE 260. G7 VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. G7 VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. G7 VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 263. G7 VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 264. G7 VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 265. G7 VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 266. G7 VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 267. G7 VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, 2018-2032 (USD MILLION)
  • TABLE 275. BRICS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 278. BRICS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPEAN UNION VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPEAN UNION VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 294. EUROPEAN UNION VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 296. EUROPEAN UNION VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 298. EUROPEAN UNION VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 300. ASEAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 301. ASEAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. ASEAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 303. ASEAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
  • TABLE 304. ASEAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 305. ASEAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 306. ASEAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, 2018-2032 (USD MILLION)
  • TABLE 307. ASEAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, 2018-2032 (USD MILLION)
  • TABLE 308. ASEAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 309. ASEAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 310. ASEAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 311. ASEAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 312. ASEAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 313. ASEAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 314. ASEAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 315. ASEAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 316. GCC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 317. GCC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 318. GCC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 319. GCC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
  • TABLE 320. GCC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 321. GCC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 322. GCC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, 2018-2032 (USD MILLION)
  • TABLE 323. GCC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, 2018-2032 (USD MILLION)
  • TABLE 324. GCC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 325. GCC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 326. GCC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 327. GCC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 328. GCC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 329. GCC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 330. GCC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 331. GCC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 332. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 333. CHINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 334. CHINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 335. CHINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 336. CHINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
  • TABLE 337. CHINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 338. CHINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 339. CHINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, 2018-2032 (USD MILLION)
  • TABLE 340. CHINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, 2018-2032 (USD MILLION)
  • TABLE 341. CHINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 342. CHINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 343. CHINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 344. CHINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 345. CHINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)

TABLE 34